The company’s two core product lines, heart defibrillators and spine products, performed under expectations. However, the company reported a 2 percent increase in revenue for the fourth quarter to $4.3 billion.
The company’s full year revenue represented a 1 percent increase over fiscal year 2010. The company’s spinal, neuromodulation, diabetes and surgical technologies group reported worldwide sales of $7.4 billion for the year, a 2 percent increase over last year.
During the fourth quarter, the spinal revenue increased 1 percent to $875 million, and international sales were up 12 percent. The company attributes this success to sales of the Solera posterior fixation system and Atlantis Vision Elite cervical plate.
Read the release on Medtronic’s financial report.
Related Articles on Medtronic:
Medtronic Releases Atlantis Vision Elite Anterior Cerivcal Plate System
Medtronic to Cut Up to 2,000 Jobs After Reporting 3Q Financial Growth
Medtronic Launches Vertex Select Chromaloy Plus Rods
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
